Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Porphyria cutanea tarda as a predictor of poor response to interferon alfa therapy in chronic hepatitis C.

Scandinavian journal of gastroenterology - 1 Mar 2003

Fernández I, Castellano G, de Salamanca R E, Colina F, Gómez de la Cámara A, Morán M J, Muñoz R, Solís-Herruzo J A

Abstract excerpt

BACKGROUND: Porphyria cutanea tarda (PCT) is sometimes associated with hepatitis C virus chronic infection. The aim of this study was to describe the effect of interferon alfa (IFN-alpha) in the treatment of patients with chronic hepatitis C and PCT. METHODS: We treated a total of 66 patients wit...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Drug Resistance, Viral
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon Type I

Share to Neutropenia

Share to Porphyria Cutanea Tarda

Share to Viral Load

Source

Identifiers

PMID: 12737448

Genes

HFE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-12737448-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Porphyria cutanea tarda as a predictor of poor response to interferon alfa therapy in chronic hepatitis C.PMID 12737448Read ↗

Evolution of HCV associated porphyria cutanea tarda after HCV sustained virologic response by direct acting antivirals.Semantic proximity Read ↗

Porphyria cutanea tarda as a complication of therapy for chronic hepatitis C.Semantic proximity Read ↗

Porphyria cutanea tarda in an HCV-positive liver transplant patient: a case report.Semantic proximity Read ↗

Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection.Semantic proximity Read ↗

Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C.Semantic proximity Read ↗

Porphyria Cutanea Tarda and Patterns of Long-term Sick Leave and Disability Pension: a 24-year Nationwide Matched Cohort StudySemantic proximity Read ↗

Hepatitis C virus in patients with porphyria cutanea tarda: relationship to HCV-genotypes.Semantic proximity Read ↗

High prevalence of hepatitis C virus type 1b in Italian patients with Porphyria cutanea tarda.Semantic proximity Read ↗

Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.Semantic proximity Read ↗

Hepatitis C virus and GBV-C/hepatitis G virus in Argentine patients with porphyria cutanea tarda.Semantic proximity Read ↗

Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study.Semantic proximity Read ↗

[Porphyria cutanea tarda. An analysis of HFE gene mutations, hepatitis viruses, alcohol intake, and other risk factors in 54 patients from Guipúzcoa, Basque Country, Spain].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.